ondasdechoque.org
PT-BR

Fracture healing, delayed union and nonunion · Review · 2025

Can shockwave ease pain after a broken bone?

This review covered 39 trials of physical treatments for fractures, and one tested shockwave. In that study, pain eased more with shockwave than in the comparison group, by about 0.5 points. The review gave no clear healing results for shockwave.

Possible early help for pain after a fracture
trials of physical treatments for fractures
39
of them tested shockwave
1
people in the whole review
2,379

Good to know: Only one study in this review used shockwave, and its treatment details were not given.

Li L, Yang L, Yang Y, et al. Frontiers in Medicine, 2025 · Read the paper ↗

How this study worked

1 studiesOne answer
A review gathers earlier studies to answer one question.

What happened

shockwave studies
1
Compared with
No added treatment (the trial's control group)

Pain relief after a fracture

Extra pain relief with shockwave, in pain-scale points

In the one shockwave study, pain eased about 0.5 points more with shockwave than in the comparison group.
Show the numbers
Difference (pain score points)likely range
Pain relief, shockwave vs comparison+0.520.16 to 0.88

What the trials used

ESWT for fracture care
The review included one ESWT study among 39 RCTs; no ESWT-specific device, energy, shock count or session protocol is stated in the accessible Results. The review reports ESWT subgroup findings for pain and complete fracture healing, but individual-trial protocol details are not available in the extracted main text.

Who took part

Adults and children with fresh or slow-healing fractures in 39 trials; one trial used shockwave.

Side effects

The review does not report side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Adults and children with fractures or delayed fracture healing; 39 RCTs (2,379 participants) covered multiple fracture sites and modalities. Only one included study evaluated ESWT.

Difference between pre-treatment and after-final-session VAS; positive MD indicates improvement as defined by article1 reported outcome
01
After final treatment; included studies ranged 5 days–6 months

Pain reduction after fracture

Difference between pre-treatment and after-final-session VAS; positive MD indicates improvement as defined by article MD VAS points (95% CI)

MD0.52CI 95% 0.16 to 0.88p = 0.004

ESWT subgroup versus control group (Table 1 lists the trial’s comparator as “none”); positive difference represents pain reduction

1 study

-0.1Equal results 01

The review reported a statistically significant pain reduction estimate for the single ESWT study (MD 0.52, 95% CI 0.16 to 0.88; p=0.004).

Analysis details and source

Pain synthesis showed high overall heterogeneity (I² 90.8%). I² could not be calculated for ESWT because only one study contributed. Follow-up across the broader outcome ranged 5 days to 6 months. Table 1 lists a 12-month follow-up for the single ESWT study (Wang et al.), longer than the 5-day to 6-month range the text gives for the pain outcome; the review does not say when that study’s pain score was taken. In the network meta-analysis, the review gives ESWT vs LLLT MD −1.74 (95% CI −3.94 to 0.45) among the comparisons suggesting LLLT may relieve post-fracture pain more, and Table 2 gives ESWT a SUCRA of 41.0% for pain.

Number of cases achieving complete fracture healing1 reported outcome
02
Follow-up varied 1 month–2.4 years

Complete fracture healing

Number of cases achieving complete fracture healing ESWT-versus-control RR not reported in narrative

The review reports overall physical modalities RR 1.37 (95% CI 1.17–1.60) versus control, but does not give the ESWT-versus-control subgroup estimate in the narrative (it appears only in Figure 3C, which was not available). Do not attribute the overall estimate to ESWT.

Analysis details and source

The NMA found most pairwise modality comparisons included the null; for ESWT the text reports CCEFS vs ESWT RR 12.61 (95% CI 0.70 to 228.37), and main-text Table 2 gives ESWT a SUCRA of 30.20% for complete healing. The full ranking table of pairwise comparisons (Supplementary Table 2) was unavailable.

How treatment was delivered
ESWT for fracture care

The review included one ESWT study among 39 RCTs; no ESWT-specific device, energy, shock count or session protocol is stated in the accessible Results. The review reports ESWT subgroup findings for pain and complete fracture healing, but individual-trial protocol details are not available in the extracted main text.

HARMS & TOLERABILITY

The review did not provide ESWT-specific adverse-event counts. The Discussion mentions possible secondary injury, hematoma and increased pain as potential ESWT risks, not observed trial rates.

LIMITS OF THE ANALYSIS

Only one study evaluated ESWT; fracture sites, populations, treatment duration and device parameters varied across the overall review. Heterogeneity was high for pain (I² 90.8%) and confidence intervals and relative comparisons were often imprecise. Study-level protocol details are not given in the main text, and the supplementary ranking table of pairwise comparisons (Supplementary Table 2) was not retrieved. SUCRA rankings do not incorporate evidence quality.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Only one study evaluated ESWT; fracture sites, populations, treatment duration and device parameters varied across the overall review. Heterogeneity was high for pain (I² 90.8%) and confidence intervals and relative comparisons were often imprecise. Study-level protocol details are not given in the main text, and the supplementary ranking table of pairwise comparisons (Supplementary Table 2) was not retrieved. SUCRA rankings do not incorporate evidence quality.
Research review

Source-linked critical reading

Systematic review with network meta-analysis

Reading depthMaterial consulted
Technical source record

Read complete XML, both raw tables, six figure captions, study-selection/characteristics, ESWT pain and healing analyses, network narrative, harms discussion, limitations and end matter. Supplementary rankings were unavailable.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review and network meta-analysis of randomized trials registered in PROSPERO (CRD420251030229), with searches through April 2025. Thirty-nine RCTs and 2,379 participants were included.

Participants

Included fracture patients ranged from age 5 to 72 years according to the text (Table 1 lists group mean ages up to 80.26 years), with varied fracture sites and healing status. Only one included study evaluated ESWT.

Intervention

The review categorized ESWT among physical agent modalities but does not provide sufficient ESWT-specific device or treatment parameters in accessible main-text results.

Comparator

Control groups received placebo stimulation or standard treatment; the single ESWT study’s exact comparator details are not reproduced with its pain result in the narrative.

Outcomes

The review assessed pain change, time to complete healing and number of complete healing cases. For pain, the single-study ESWT subgroup estimate was MD 0.52 (95% CI 0.16 to 0.88; p=0.004); positive difference was defined by the article as improvement.

Comparative findings

Pain analyses had substantial overall heterogeneity (I² 90.8%). A single ESWT study contributed, so subgroup heterogeneity could not be estimated. The review’s overall complete-healing RR must not be attributed to ESWT.

Harms

No ESWT-specific adverse-event counts were reported. Potential hematoma, increased pain and secondary injury were discussed as possible risks, not trial event rates.

Limitations

The review included one ESWT study amid diverse fracture populations and modalities. Study protocol details and the supplementary pairwise ranking table (Supplementary Table 2) were unavailable; confidence and generalizability are limited.

Applicability

This is preliminary evidence from a single study and does not establish a reliable ESWT effect for any particular fracture type or treatment protocol.

Research needs

Future trials should report fracture type, healing stage, device settings, treatment schedule, comparator, validated pain measures, healing definitions, harms and adequately powered comparative outcomes.

THE ORIGINAL SOURCE

Read the original article.

Evaluation of the efficacy of physical agent modalities in patients with fractures: a systematic review and network meta-analysis.

Li L, Yang L, Yang Y, Zhu J, Shi R, Deng Q, Wang J, Sun F. · Frontiers in medicine · 2025

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →